Lv1
34 积分 2024-03-01 加入
Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
1个月前
已完结
Allogeneic CAR-T cells in lupus: Bridging the gap for a new therapeutic era?
1个月前
已完结
From innate power to intelligent design: The evolution of NK cell-based cancer immunotherapy
2个月前
已关闭
Patient-derived induced pluripotent stem cells with a C9orf72 expansion as a model to study frontotemporal dementia pathologies
2个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
6个月前
已完结
Human stem cell-specific epigenetic signatures control transgene expression
6个月前
已完结
皖公网安备34019202002308
